Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells

Figure 6 Rescue experiment. A: miR-34c inhibitor could counteract the effect of si E2F1 on related proteins. ^aP < 0.05, and ^bP < 0.01; B: miR-34c inhibitor could offset the inhibitory effect of si E2F1 on cell activity. ^aP < 0.05 vs other groups; C: miR-34c inhibitor neutralized the sensitization effect of si-E2FL on cell resistance. ^bP < 0.01, and ^eP < 0.001; D: miR-34c inhibitor inhibited the effect of si-E2FL on apoptosis. ^aP < 0.05, ^bP < 0.01, and ^eP < 0.001; E: miR-34c inhibitor inhibited the inhibitory effect of si-E2FL on S-phase cells. ^bP < 0.01 and ^eP < 0.001.